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Abstract
Background: Ossifying metaplasia is an unusual feature of urothelial carcinoma, with only a few cases reported.
The largest series included 17 cases and was published in 1991. The mechanism of ossification is unknown and
hypotheses of osteogenic precursor cells, inducing bone formation, are proposed.
Case presentation: A 75 year-old patient was treated for a high grade transitional cell carcinoma of the bladder by
surgery, chemotherapy and radiotherapy. Histology showed foci of bone metaplasia, both at the periphery of the
tumor, and in a lymph node metastasis. 1 year later, a heterotopic bone formation was discovered in the right
retroperitoneal space, near the lumbar spine, increasing rapidly in size during follow-up. Several imaging exams were
performed (2 CT, 1 MRI, 1 Pet-CT), but in the absence of typical features of sarcoma, diagnosis remained unclear.
Histology of a CT-guided percutaneous biopsy showed urothelial carcinoma and mature lamellar bone. Integration of
these findings with the radiological description of extraosseous localization was consistent with a diagnosis of osseous
metaplasia of an urothelial carcinoma metastasis. The absence of bone atypia in both the primary and metastases
argues against sarcomatoid urothelial carcinoma with osteosarcomatous differentiation.
Conclusion: Osseous metaplasia of an urothelial carcinoma metastasis is unusual, and difficult to distinguish from
radiotherapy induced sarcoma, or from sarcomatoid carcinoma. Rapid progression, sheathing of adjacent structures
such as vessels (like inferior vena cava in our case) and nerves and bony feature of lymph node metastases necessitate
histological confirmation and rapid treatment. Our case illustrates this disease and evaluates the imaging features.
In addition we discuss the differential diagnosis of osseous retroperitoneal masses.
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Background
Osseous metaplasia is rarely observed in the stroma of
bladder carcinoma, either in the primary tumor [1] or in a
metastasis. In an article published in 1991 by Robert H.,
17 cases were reviewed [2], with only a few more cases re-
ported since then [3]. This additional finding in itself is
considered benign; the main challenge is to differentiate
osseous metaplasia from sarcomatoid carcinoma with
osteosarcomatous differentiation or from radiation in-
duced osteosarcoma, that would obviously change both
the course of the disease and the treatment [2, 4].
Although the mechanisms are still hypothetical, osteo-
genic precursor cells, a favorable microenvironment,
and ossification-inducing stimuli are prerequisites to
the heterotopic formation of bone. The hypothesis is
that a clone of tumor cells produces bone foci by indu-
cing osteogenesis.
Imaging revealed an osseous mass in the retroperi-
toneal space, infiltrating posterior structures including
vessels and nerves and generating compression of adja-
cent tissues with bone invasion. We report the case of
an osseous metaplasia in urothelial carcinoma, both in
the primary and in metastases. This case is illustrative
of the course of the disease with its imaging features
(which are not specific), and allows discussion of the
main differential diagnoses, particularly sarcoma and
other rare ossifying pathologies.
Case presentation
A 75-year-old man was treated for a high-grade bladder
urothelial carcinoma (pT3b N1) by endoscopic resection of
the bladder with neo-adjuvant chemotherapy, followed by
a right nephro-uretrectomy, a radical cysto-prostatectomy
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and bilateral ilio-obturator lymph node dissection. Macro-
scopic invasion of perivesical soft tissue was observed, and
histology showed poorly differentiated carcinoma (Fig. 1a),
with perineural invasion. On the deep leading edge of the
tumor, small foci of osteomedullary bone metaplasia were
observed (Fig. 1b). Non atypical osteocytes were seen
within trabeculae of mature-appearing lamellar bone. Two
out of seven lymph nodes were metastatic, among which
one showed a focus of parahilar bone metaplasia (Fig. 1c).
Reactivity to p63 is expected in 81-92 % of high grade
urothelial carcinomas [5] accordingly both the primary
tumor cells and a lymph node metastasis showed reactivity
to squamous-associated marker p63 (clone 7JUL, mouse
monoclonal, Novocastra).
Treatment was completed by adjuvant chemotherapy
and radiotherapy for positive lymph nodes. Two years
later, during normally scheduled imaging follow up, the
apparition of several osseous formations localized in the
right retroperitoneal space within the psoas muscle at the
level of the bodies of 4th and 5th lumbar vertebra was
noted (Fig. 2). The formations were very dense on CT
(like cortical bone), lobulated and in continuity with nor-
mal bone with a parosteal location (Fig. 3). The largest
mass measured initially 4 cm. A PET-CT (Fig. 4) showed
that the mass situated in the right lower quadrant was
moderately hypermetabolic with a max SUV of 5.1.
A complementary MRI (Fig. 5) was performed and the
lesions appeared hypointense on all sequences with thin
peripheral enhancement. The multidisciplinary discussion
recommended a control CT after 3 months. At control the
osseous formations increased in size with vessel sheathing,
including the inferior vena cava, lumbar arteries and also
the 5th right spinal ganglia without extension in the for-
amina (Fig. 6). In addition, it showed the development of
further foci of bone formation in pelvic ganglia sites bilat-
erally. Considering the rapid progression of the disease
and the absence of a clear diagnosis, a percutaneous bi-
opsy was scheduled. The procedure was performed under
CT guidance (VCT,GE healthcare, Milwaukee, Wis) with
anaesthetic stand-by using a Bonopty 16G/15 cm needle
(AprioMed/Bonopty Bone Biopsy System) (Fig. 7).
Histological study of the biopsy showed mainly crush ar-
tifacts, but also minute foci of lamellar bone trabeculae as-
sociated with broad spectrum keratin (clones AE1/AE3,
mouse monoclonal, Dako) and p63 positive epithelial cells
consistent with metastatic urothelial carcinoma (Fig. 8).
Again, the bone trabeculae displayed no atypical features.
At the time of this report, the patient is still alive and
only the mentioned lesions are progressing, without
response to additional radiotherapy.
Discussion
Bone formation in the stroma of bladder carcinoma or in
heterotopic sites has been noted in a few reports [6–8]. 17
cases were reported in a review of unusual bladder carcin-
oma, published in 1991. These bone formation concerned
the primitive tumor and in the majority of the reported
cases, the tissue was benign-appearing [2, 3, 6]. The de-
gree of calcification is reported from minimal to complete
as in our case with a stony feature. Clones of tumour cells
may induce osteogenesis leading to osseous development
as transitional epithelium is a well-known bone-inducing
agent [9]. However, bone production by tumor cells would
indicate osteosarcomatous differentiation. The main hy-
pothesis would be a transformation of undifferentiated
stromal mesenchymal cells into osteoblasts [10]. Bone
morphogenetic proteins (BMP) are known to induce pri-
mary new bone formation at heterotopic, extraosseous
sites [11]. In particular, involvement of bone morpho-
genetic protein 2 (BMP-2) produced by tumor cells [12] in
both primary and metastatic sites as well as the expression
of a BMP type 1 receptor called BMP-Ib in the metastatic
sites, were all reported to play a role in the osseous forma-
tion. (BMP 2) is admitted as an active inducer of osteo-
blastic metaplasia in primary site and BMP-Ib as a
precursor in metastatic site. They act as cytokine, target
Fig. 1 Histological findings at the time of the primary tumor resection (Hematoxylin & Eosin, H&E): The primary tumor consisted of a high grade
urothelial carcinoma infiltrating the bladder wall; at the periphery of the tumor, a small focus of osteomedullary bone intimately admixed with
the urothelial carcinoma was composed of small and non atypical osteocytes within mature-appearing trabeculae of lamellar bone (a, Original
magnification 20× and b, 200×). c: a focus of bone metaplasia is seen at the hilum of a metastatic lymph node (100×)
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multipotent cells and induce differentiation of mesenchy-
matal cells onto osteoblasts [10]. That heterotopic ossifi-
cation might be an indicator of aggressiveness of tumor
without characteristic morphological features of carcino-
sarcoma or primary osteosarcoma (absence of mesenchy-
matal cell proliferation, stromal cell mitosis and lack of
sarcomatoid elements) [4]. The characteristics of this en-
tity are not fully described nor understood. The degree of
invasion, the course of the disease, the optimal treatment
and the prognosis parameters are not known. These pa-
rameters should be further determined [13].
To our knowledge, this is the first reported case focus-
ing on the aggressiveness of these metastases illustrated
by a multimodality imaging approach. CT represents the
best imaging procedure, and shows multiple osseous for-
mations, located in the retroperitoneal space following
lymph nodes sites, sheathing adjacent vessels, that may
encase nerves and spinal ganglia, as in our case. Another
Fig. 2 Follow-up CT performed 1 year after surgery (a) shows a small calcified nodule (white arrow) in the right retroperitoneal space. 6 months
later (b) the calcified mass has increased in size. On another control 6 (c) months later the ossification progressed in size and into the adjacent
vertebra (black arrow)
Fig. 3 Coronal reformat of a CT shows the multifocal ossifications along the retroperitoneal space (black arrowheads) as well as the intravertebral
extension (black arrow). A calcified nodule is seen in the left inguinal area (white arrow)
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finding was the invasion of adjacent bones with the same
matrix. Furthermore, CT allows follow up of the lesions
and detection of new lesions. The metabolic activity re-
corded on the PET-CT was moderate and the imaging
pattern on MRI was non-specific, the osseous lesions
appearing hypointense in all the sequences. The diffusion
sequence does not contribute to the characterization of
the lesion matrix due to the pronounced hypointensity on
T2 sequences.
The case presented here showed rapid progression of
the disease with risk of local compression; no vascular
erosion or fracture was noted during the follow up
period of 2 years and a half. This osseous metaplasia
leads to the differential diagnosis of bone formation. In
the context of carcinoma treated with radiotherapy and
if the disease appears in the irradiation field, a radiation
induced sarcoma should be the first suspected diagnosis.
It is a well-known entity and the major criteria for the
definition, controversial in the literature, is the length
between radiation exposure and tumor formation: it
seems that a latency of 6 months is sufficient to affirm
the diagnosis in some cases [14]. Extraskeletekal osteo-
sarcoma is more common after radiation therapy than
spontaneous formation, and represents 1-2 % of all soft
tissue sarcoma and 4 % of all osteosarcomas; the retro-
peritoneal space is involved in 17 % of cases. It occurs
after 40 years of age. Prognosis is poor with a 5-years
survival of about 11 % [15, 16]. Imaging studies show
variable amounts of ossification in the tumor [17].
These areas are heterogeneous with focal hypoattenua-
tion on CT and intermediate signal on T1 with enhance-
ment [16] or low signal both in T1 and T2 sequences [18].
Areas with low attenuation are visible due to necrosis or
hemorrhage. Local invasion can be encountered.
Malignant bone formation can be a feature of the sar-
comatoid variant of infiltrating urothelial carcinoma, a
Fig. 4 PET (a) and PET-CT fused axial slices (b) demonstrate the moderately hypermetabolic (SUV max 5.1) lesion of the retroperitoneum
Fig. 5 Axial MRI shows the lesions as hypointense on T2 (a) and T1 (b), with peripheral enhancement (arrow) on T1 fat sat after injection of
contrast (c)
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well recognised entity [19], considered to be aggressive
and of poor prognosis. Malignant heterologous elements
can be observed in sarcomatous carcinomas of various
organs, including urinary bladder; the malignant mesen-
chymal elements are produced by the carcinoma cells.
However, no atypical features were observed in the het-
erotopic bone foci, both in the primary tumor and in the
lymph node and retroperitonel metastases. The histo-
logical criteria of osteosarcoma were thus not met. From
a contrasting point of view, osteoblastic bone metastases
consist of benign bone trabeculae produced by non ma-
lignant osteoblasts under the influence of cytokines se-
creted by the carcinoma cells, an example typical for
bone metastases of adenocarcinoma of the prostate.
However, not one of the observed bone foci was in an
intraosseous localization. Therefore, we believe bone for-
mation in the case presented here represents metaplasia,
defined by the production of benign elements in unusual
places. Ossifying metaplasia thus refers to the produc-
tion of reactive benign bone trabeculae. As the mass was
osseous, a myositis ossificans and a melorheostosis
should also be discussed.
Myositis ossificans is a benign solitary soft tissue ossify-
ing mass in skeletal muscle, with a history of traumatism.
The pattern of peripheral ossification is important to estab-
lish the diagnosis; mature forms may present a complete
Fig. 6 Axial CT slices (a, b) depict the sheating of the vessels by the ossified mass (arrow) as well as the sheating of the lumbar
nerves (arrowheads)
Fig. 7 A percutaneous biopsy was performed under CT guidance using a Bonopty 16G biopsy set
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ossification [20]. The lesion is intramuscular, predomin-
antly localized at sites of injury, and can occur almost any-
where. The CT gives a specific pattern with a well limited
high attenuating periphery and a low attenuating central
portion. On MRI, it is isointense in T1, hyperintense in T2
with enhancement after injection [21].
Melorheostosis is defined as a rare sclerosing bone dys-
plasia with a characteristic linear sclerosis of cortical bone;
calcification and ossification of soft tissues are typically
found near the large joints. It appears as low signal intensity
in all MR sequences but intermediate signal is described
with enhancement in soft tissue masses [22, 23]. Computed
tomography demonstrates a well matured ossified mass.
Bone scintigraphy shows moderately uptake of tracer.
Tumoral calcinosis can also be discussed in the presence
of a massively calcified mass [24]. It is a rare disease, a
complication of chronic renal failure. The main features
are the lobulated aspect and the periarticular location. It
affects young adults and appears in imaging exams as a
heterogeneous dense mass without bone involvement.
Amyloidosis was also considered in the differential diag-
nosis. It is a heterogeneous group of disorders and in sys-
temic form, amyloid may infiltrate the retroperitoneal and
pelvic soft tissues and undergo gradually progressive calci-
fication over time with formation of soft tissue thickening,
encasing the urinary tract and involving renal sinus. CT
shows amorphous calcification associated with tissue
thickening, MRI demonstrates intermediate signal inten-
sity on T1 and decreased signal intensity on T2 [25].
Other rare, benign neoplastic causes of calcified masses
in the pelvic retroperitoneum include ganglioneuroma,
schwannoma, paraganglioma, hemangioma, and presacral
teratoma [26].
Conclusion
To the best of our knowledge, this is the first reported
case of retroperitoneal osseous metaplasia in a urothelial
carcinoma metastasis studied with different imaging mo-
dalities and confirmed with percutaneous, CT guided bi-
opsy. In this case we also demonstrated the aggressiveness
of the disease, the rapid progression and the sheathing
characteristic of adjacent organs including vessels and
nerves. Sarcomatous carcinoma and radiation induced
osteosarcoma are the most challenging differential diagno-
ses even though delay was short.
Prognosis is likely determined by the extent of the
high grade urothelial carcinoma, but independent of the
benign metaplastic bone component.
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